Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
629 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02445014 | Pilot Study to Image the Esophagus Using a SECM Tethered Endoscopic Capsule(SECM) | completed | N/A | 3 | Massachusetts General HospitalOTHER | 1 | Aug 21, 2020 | clinicaltrials |
| NCT00652119 | Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin | unknown | Phase 1 | 46 | Massachusetts General HospitalOTHER | 1 | Aug 19, 2020 |
| NCT01228448 | In-Room PET in Proton Radiation Therapy | completed | N/A | 59 | Massachusetts General HospitalOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT01485744 | LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer | completed | Phase 1 | 39 | Massachusetts General HospitalOTHER | 1 | Aug 4, 2020 | clinicaltrials |
| NCT02428855 | Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma | completed | Phase 2 | 8 | Massachusetts General HospitalOTHER | 1 | Jul 31, 2020 | clinicaltrials |
| NCT01746251 | Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation | unknown | Phase 2 | 92 | Massachusetts General HospitalOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT02003625 | Meloxicam vs Placebo for Mobilization | completed | Phase 2 | 31 | Massachusetts General HospitalOTHER | 1 | May 18, 2020 | clinicaltrials |
| NCT04388735 | Multiple Myeloma (MM) Quality of Life (QOL) Study | unknown | — | 360 | Massachusetts General HospitalOTHER | 1 | May 14, 2020 | clinicaltrials |
| NCT00756106 | MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma | terminated | N/A | 15 | Massachusetts General HospitalOTHER | 1 | May 13, 2020 | clinicaltrials |
| NCT02560025 | Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML | completed | Phase 2 | 42 | Massachusetts General HospitalOTHER | 1 | May 5, 2020 | clinicaltrials |
| NCT02431572 | A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy | completed | N/A | 11 | Massachusetts General HospitalOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT01775501 | Sorafenib + mFOLFOX for Hepatocellular Carcinoma | completed | Phase 2 | 40 | Massachusetts General HospitalOTHER | 1 | Apr 22, 2020 | clinicaltrials |
| NCT03226405 | Patient Navigation to Improve Patient-Centered Cancer Care | unknown | N/A | 400 | Massachusetts General HospitalOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT01830777 | Brentuximab Vedotin + Re-induction Chemotherapy for AML | completed | Phase 1 | 22 | Massachusetts General HospitalOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT00854139 | Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD) | completed | Phase 1 | 10 | Massachusetts General HospitalOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT01813734 | Ponatinib in Advanced NSCLC w/ RET Translocations | completed | Phase 2 | 9 | Massachusetts General HospitalOTHER | 1 | Dec 24, 2019 | clinicaltrials |
| NCT02228772 | Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults | completed | Phase 1 | 19 | Massachusetts General HospitalOTHER | 1 | Nov 26, 2019 | clinicaltrials |
| NCT01439594 | Optical Frequency Domain Imaging (OFDI) Assessment in Radiofrequency Ablation(OFDI) | completed | N/A | 17 | Massachusetts General HospitalOTHER | 1 | Nov 22, 2019 | clinicaltrials |
| NCT02150863 | Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study | terminated | N/A | 1 | Massachusetts General HospitalOTHER | 1 | Nov 18, 2019 | clinicaltrials |
| NCT03340402 | Preoperative Accelerated Partial Breast Irradiation for Triple Negative Breast Cancer Using Proton Beam Scanning | withdrawn | N/A | 0 | Massachusetts General HospitalOTHER | 1 | Nov 14, 2019 | clinicaltrials |
| NCT01871506 | Integrating Tobacco Treatment Into Cancer Care: A Randomized Controlled Comparative Effectiveness Trial | completed | N/A | 303 | Massachusetts General HospitalOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT03657420 | Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma | withdrawn | Phase 1 | 0 | Massachusetts General HospitalOTHER | 1 | Aug 14, 2019 | clinicaltrials |
| NCT03807089 | Adenoma Detection Rate With a New Pediatric Colonoscope With a Short Turn Radius (Pentax Retroview) Compared With a Standard Pentax Pediatric Colonoscope | completed | N/A | 283 | Massachusetts General HospitalOTHER | 0 | Jul 16, 2019 | clinicaltrials |
| NCT03749083 | A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer | withdrawn | — | 0 | Massachusetts General HospitalOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT03057509 | A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors | withdrawn | Phase 1 | 0 | Massachusetts General HospitalOTHER | 1 | Jun 21, 2019 | clinicaltrials |
| NCT02204150 | Study to Image the Esophagus Using the OFDI Capsule | completed | N/A | 56 | Massachusetts General HospitalOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT02033486 | Digital Breast Tomosynthesis Guided Tomographic Optical Breast Imaging (TOBI) | unknown | N/A | 375 | Massachusetts General HospitalOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT01439633 | Optical Frequency Domain Imaging (OFDI) Surveillance and Image Guided Biopsy of the Esophagus | completed | N/A | 22 | Massachusetts General HospitalOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT02210039 | Using Spectrally Encoded Confocal Microscopy (SECM) to Visualise the Esophagus Using an SECM Probe | completed | N/A | 6 | Massachusetts General HospitalOTHER | 1 | Apr 3, 2019 | clinicaltrials |
| NCT03494244 | Evaluation of ADM Soft Tissue Reinforcement | unknown | — | 152 | Massachusetts General HospitalOTHER | 0 | Mar 12, 2019 | clinicaltrials |
| NCT02132221 | Cessation of Long-term Opioid Therapy in Chronic Pain Patients | terminated | N/A | 6 | Massachusetts General HospitalOTHER | 1 | Mar 8, 2019 | clinicaltrials |
| NCT02813902 | A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors | withdrawn | Phase 1 | 0 | Massachusetts General HospitalOTHER | 0 | Mar 8, 2019 | clinicaltrials |
| NCT03220100 | Study of Stepped Palliative Care in Patients With Advanced Lung Cancer DF/HCC SOCIAL-BEHAVIORAL RESERACH PROTOCOL | terminated | N/A | 11 | Massachusetts General HospitalOTHER | 1 | Mar 8, 2019 | clinicaltrials |
| NCT02871739 | A Trial Comparing Approaches to Shared Decision Making Skills Training for Clinicians | completed | N/A | 23 | Massachusetts General HospitalOTHER | 0 | Feb 8, 2019 | clinicaltrials |
| NCT00438256 | Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer | completed | Phase 1 / Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT01408563 | Reduced Intensity Double Umbilical Cord Blood Transplantation | completed | Phase 2 | 33 | Massachusetts General HospitalOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT01846871 | Tivozanib for Recurrent Glioblastoma | completed | Phase 2 | 10 | Massachusetts General HospitalOTHER | 1 | Jan 8, 2019 | clinicaltrials |
| NCT01282502 | Midostaurin (PKC412) for Locally Advanced Rectal Cancer | completed | Phase 1 | 19 | Massachusetts General HospitalOTHER | 1 | Dec 12, 2018 | clinicaltrials |
| NCT00567359 | Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR | completed | Phase 2 | 100 | Massachusetts General HospitalOTHER | 1 | Dec 11, 2018 | clinicaltrials |
| NCT02157519 | Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer | completed | N/A | 212 | Massachusetts General HospitalOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT01782963 | Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)(RVD Lite) | completed | Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT00580398 | Smoking Cessation Intervention for Thoracic Patients | completed | Phase 1 / Phase 2 | 49 | Massachusetts General HospitalOTHER | 1 | Oct 12, 2018 | clinicaltrials |
| NCT01906437 | Cardiac Fibrosis by CMR in Patients With Cancer | withdrawn | — | 0 | Massachusetts General HospitalOTHER | 1 | Sep 14, 2018 | clinicaltrials |
| NCT02286466 | Mobile App of CBT for Anxiety and Cancer | completed | N/A | 145 | Massachusetts General HospitalOTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT02387177 | Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype | completed | N/A | 51 | Massachusetts General HospitalOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT02811718 | Resiliency Training for Patients With NF2 Via Videoconferencing With Skype | completed | N/A | 45 | Massachusetts General HospitalOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT01112527 | PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma | completed | Phase 2 | 58 | Massachusetts General HospitalOTHER | 1 | Aug 16, 2018 | clinicaltrials |
| NCT01389778 | Polycystic Ovary Syndrome Genetics and Treatment Response | unknown | N/A | 200 | Massachusetts General HospitalOTHER | 1 | Aug 16, 2018 | clinicaltrials |
| NCT02198417 | Metformin Treatment in Polycystic Ovary Syndrome (PCOS) | unknown | N/A | 20 | Massachusetts General HospitalOTHER | 0 | Aug 16, 2018 | clinicaltrials |
| NCT01652079 | CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer | completed | Phase 2 | 63 | Massachusetts General HospitalOTHER | 1 | Jul 2, 2018 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials